Entries by Thomas Gabrielczyk

CJEU ruling triggers exodus of EU plant research

According to a brand-new EU-wide survey, European plant researchers are concerned about the European Court of Justice‘s (CJEU) interpretation that targeted mutation methods aimed at improving crop yield and resistance to climate change yield GMOs. In an open letter, they call for political action and a modernisation of the EU Directive 2001/18/EC because a lack in tech-transfer would put Europe at the bottom of the pile in the upcoming bioeconomy.

Boehringer expands neurology activities

Boehringer Ingelheim has expanded its 2014 R&D collaboration with the BioMed X Innovation Center (Heidelberg, Germany) to find new treatment approaches for early intervention of psychiatric diseases.

Highest manufacturing standard: First Line

Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global health care world. Our unique product range includes the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. These are based on a broad spectrum of experience in the healthcare industry. To ensure the highest quality in our broad product portfolio, we have implemented the most advanced manufacturing standard.

Drug dissociates metastasis precursors in blood

A team of Swiss researchers has identified Na+/K+-ATPase blockers as candidate drugs capable to prevent formation of metastases. In blood, the repurposed drugs identified in a screening dissociated clusters of circulating tumour cells (CTCs), forerunners of metastases.

Sandoz’ antiinfectives partner Ares Genetics gets fund

Just in mid-December, antibiotic resistance detection expert Ares Genetics (Vienna, Austria) inked an agreement with Sandoz to use its pathogenome database and bio-IT know-how to develop repurposed and novel antiinfectives that help fight antimicrobial resistance (AMR). Now, the company baged another financing to expand its diagnostic capabilities.